CONMED Corporation to Present at the J.P. Morgan Healthcare Conference

Rhea-AI Summary

CONMED (NYSE: CNMD) has announced its upcoming participation in the J.P. Morgan Healthcare Conference. The company's leadership, including President and CEO Patrick J. Beyer and Executive Vice President and CFO Todd W. Garner, will deliver a presentation on Monday, January 13, 2025, at 4:30 p.m. PT (7:30 p.m. ET) in San Francisco, CA.

Investors and interested parties can access a live audio webcast of the presentation through the "Investors" section on CONMED's website at www.conmed.com. The presentation will also be available for replay after the event.

 

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan Healthcare Conference at 4:30 p.m. PT (7:30 p.m. ET) on Monday, January 13, 2025 in San Francisco, CA.

A live audio webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.conmed.com and will be available for replay following the event.

About CONMED Corporation

CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release and associated webcast may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2023, listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q and other risks and uncertainties, which may be detailed from time to time in reports filed by CONMED with the SEC. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250102519484/en/

CONMED Corporation

Todd W. Garner

Chief Financial Officer

727-214-2975

ToddGarner@conmed.com

Source: CONMED Corporation

FAQ

When is CONMED (CNMD) presenting at the J.P. Morgan Healthcare Conference 2025?

CONMED will present at the J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 4:30 p.m. PT (7:30 p.m. ET) in San Francisco, CA.

How can investors watch CONMED's (CNMD) J.P. Morgan Healthcare Conference presentation?

Investors can watch the live audio webcast through the 'Investors' section of CONMED's website at www.conmed.com. The presentation will also be available for replay after the event.

Which CNMD executives are presenting at the 2025 J.P. Morgan Healthcare Conference?

Patrick J. Beyer, President and CEO, and Todd W. Garner, Executive Vice President and CFO, will present at the conference.

Will CNMD's J.P. Morgan Healthcare Conference presentation be available for replay?

Yes, the presentation will be available for replay on CONMED's website (www.conmed.com) in the 'Investors' section following the event.